Overview

B Cell and Antibody Response to Seasonal Influenza Vaccines in Younger and Older Adults

Status:
Recruiting
Trial end date:
2023-05-01
Target enrollment:
Participant gender:
Summary
This study will examine how various FDA-approved seasonal influenza vaccine types, used in a manner consistent with their approved use, impact the characteristics of influenza specific antibodies in humans, and how these responses differ based on age and prior immunization history.
Phase:
Phase 4
Details
Lead Sponsor:
University of Alabama at Birmingham
Treatments:
Antibodies
Vaccines